Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Mais

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Journal of Medicinal Chemistry|April 26, 1996
Synthesis and biological activity of novel nonsteroidal progesterone receptor antagonists based on cyclocymopol monomethyl etherL G Hamann, L J Farmer, M G Johnson, et al.
Journal of Medicinal Chemistry|August 4, 1995
Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cellsM F Boehm, L Zhang, L Zhi, et al.
Endocrinology|March 6, 1999
The novel progesterone receptor antagonists RTI 3021-012 and RTI 3021-022 exhibit complex glucocorticoid receptor antagonist activities: implications for the development of dissociated antiprogestinsB L Wagner, G Pollio, P Giangrande, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 1, 1996
Discovery of novel intracellular receptor modulating drugsT K Jones, C Pathirana, M E Goldman, et al.
Molecular Biology of the Cell|August 1, 1996
Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXRS Kitareewan, L T Burka, K B Tomer, et al.
Chemistry & Biology|May 14, 1999
Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3M F Boehm, P Fitzgerald, A Zou, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Nonsteroidal progesterone receptor antagonists based on a conformationally-restricted subseries of 6-aryl-1,2-dihydro-2,2,4-trimethylquinolinesL G Hamann, D T Winn, C L Pooley, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Journal of Medicinal Chemistry|April 26, 1996
Synthesis and biological activity of novel nonsteroidal progesterone receptor antagonists based on cyclocymopol monomethyl etherL G Hamann, L J Farmer, M G Johnson, et al.
Journal of Medicinal Chemistry|August 4, 1995
Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cellsM F Boehm, L Zhang, L Zhi, et al.
Endocrinology|March 6, 1999
The novel progesterone receptor antagonists RTI 3021-012 and RTI 3021-022 exhibit complex glucocorticoid receptor antagonist activities: implications for the development of dissociated antiprogestinsB L Wagner, G Pollio, P Giangrande, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 1, 1996
Discovery of novel intracellular receptor modulating drugsT K Jones, C Pathirana, M E Goldman, et al.
Molecular Biology of the Cell|August 1, 1996
Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXRS Kitareewan, L T Burka, K B Tomer, et al.
Chemistry & Biology|May 14, 1999
Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3M F Boehm, P Fitzgerald, A Zou, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Nonsteroidal progesterone receptor antagonists based on a conformationally-restricted subseries of 6-aryl-1,2-dihydro-2,2,4-trimethylquinolinesL G Hamann, D T Winn, C L Pooley, et al.
Pageof 8